[1]
R. A. Syahrani, “Dual sgRNA-directed knock out survivin gene expression using CRISPR/Cas9 technology for editing survivin gene in triple-negative breast cancer”, Narra J, vol. 4, no. 3, p. e1177, Nov. 2024.